04/23/2026
Dear families.
This is the post I just now made on my personal page in case you donβt follow me. βGreat news! Learned a short time ago that the internal review board has approved Hannahβs gene therapy injection. Now, we are waiting on the surgery date. Thankfully, we see changes coming in the near future to make single patient genetic medicines much easier to access. Genetic medicines need to be treated as βproceduresβ, like bone marrow transplants, not as βstudiesβ. The culture must change within academic centers, realizing that genetic medicines are not for the next generation. They are for the patients waiting for them here and now. Working to encourage all parents developing genetic medicines for their children to demand immediate access as soon as their toxicology study is done, and the drug is in the freezer. The vast majority of genetic disorders are ultra rare. And, even within a disease indication thereβs huge phenotypic variability. Therefore, there will be no statistical analysis plan submitted with these protocols. Rather, each patientβs lead-in data will be the control data. What we have been through to make this happen for Hannah should never happen again. The whole system needs to be overhauled. Academic centers receiving federal funding must be mandated and incentivized to execute on the administration of genetic medicines, especially when the drug is being provided at no cost. And, access should also be granted to pediatric patients for fatal indications, if the parents assent. While today was another milestone met, I donβt think Iβm actually going to believe that itβs happening until Hannah is being wheeled into the operating room. π. Please continue to pray for her. (In the photo below, hannah has on her physio vest.)β